KDA GROUP REACHES FINAL CERTIFICATION PHASE FOR MEDHERIZE WITH DSQ - DOSSIER SANTÉ QUÉBEC
MWN-AI** Summary
KDA Group Inc. (TSXV: KDA) has successfully entered the final certification phase for its Medherize platform's integration with Dossier Santé Québec (DSQ). Following its initial certification phase completion in December 2024, KDA’s latest achievement was confirmed by the DSQ’s Integration and Certification Support Team on April 7, 2025, after passing the final self-assessment phase. A technical audit is scheduled for April 22-24, 2025, marking the last step before the full integration of Medherize.
The first deployment of the Medherize platform is set for May 5, 2025, at St-Sacrement Hospital Center in Québec City, with plans for broader implementation across other healthcare institutions in the province following a progressive rollout. KDA Group is now recognized as the first technology provider in Québec to certify the granular data mode for DSQ integration—advancing how clinical information is transmitted. This innovative mode allows for structured, interoperable data, as opposed to the traditional static PDF format used for lab results, which can be cumbersome to process.
KDA’s milestone highlights its pioneering role in digital health and reflects a significant shift towards enhanced efficiency, safety, and quality of care, along with reductions in delays and human error. Yves Marmet, President and CTO of KDA, emphasized the importance of this certification, while CEO Marc Lemieux commended the team’s vital contributions to the healthcare system's digital transformation.
KDA Group specializes in technological innovations and software solutions for healthcare professionals, aiming to accelerate digital transformation within the sector and expand into both Canadian and international markets. The success of Medherize reaffirms KDA's position as a leader in digital health innovations.
MWN-AI** Analysis
The recent announcement from KDA Group Inc. regarding its Medherize platform reaching the final certification phase for integration with Dossier Santé Québec (DSQ) signifies a pivotal moment not only for the company but for the healthcare technology landscape in Québec. This achievement places KDA at the forefront of digital health innovation, as it becomes the first technology provider to certify using the granular data mode. This mode facilitates dynamic and interoperable data transmission, enhancing clinical workflows and thereby potentially improving patient outcomes.
Investors should view this development as a strong positive indicator of KDA’s competitive positioning in the growing field of digital healthcare solutions. The certification, coupled with the upcoming implementation at St-Sacrement Hospital Center, underlines KDA's readiness to rollout its advanced technological offerings, which could lead to market expansion opportunities across other health institutions in the province and beyond.
From a market perspective, positive sentiment surrounding this milestone could bolster KDA's stock performance, particularly as healthcare providers increasingly seek efficient, real-time data solutions. Investors should monitor KDA's stock closely following the final audit scheduled on April 22–24, 2025, and the anticipated rollout on May 5, 2025. The broader trend towards digital transformation within healthcare may also increase the attractiveness of KDA’s offerings.
However, it is essential to remain cautious. The inherent risks cited in KDA's forward-looking statements should serve as a reminder that while market opportunities exist, potential uncertainties in execution and competition could impact growth trajectories. As KDA continues to pioneer innovations in healthcare technology, strategic investors may consider accumulation of shares around this transformative phase, while being vigilant about sector dynamics and competitive responses.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Canada NewsWire
THETFORD MINES, QC , April 15, 2025 /CNW/ - KDA Group Inc. (TSXV: KDA) (" KDA " or the " Corporation "), a leader in innovative technological solutions for healthcare professionals, is pleased to announce that it has reached the final phase in the certification process for its Medherize platform's integration with the Dossier Santé Québec (" DSQ ").
Following the successful completion of the initial certification phase announced on December 3, 2024 , all three required development phases for the module have now been completed. On April 7, 2025 , the Direction des produits de prestations de services du DSQ, through its Integration and Certification Support Team, confirmed that the final self-assessment phase was successfully passed.
The final audit is scheduled for April 22–24, 2025, marking the last technical validation before full integration. The initial deployment of Medherize is planned for May 5, 2025 , at the St-Sacrement Hospital Center in Québec City, followed by a progressive rollout across other healthcare institutions in the province.
KDA is now the first technology provider in Québec to successfully certify for DSQ integration using the granular data mode —a major advancement in the transmission of clinical information.
Unlike laboratory results delivered in PDF format, which are often static and difficult to process, the granular mode enables structured, interoperable, and seamlessly integrable data within clinical systems. This model provides substantial gains in efficiency, safety, quality of care, as well as reductions in delays and human error.
"This achievement confirms our role as a pioneer in digital health. With the certification of the granular mode, the Medherize platform can now deliver an advanced and innovative technological experience, powered by structured, automated, and real-time clinical data. It's a paradigm shift that positions Québec at the forefront of connected medicine," said Yves Marmet , President and Chief Technology Officer of Groupe Technologique KDA.
"Innovation has always been at the heart of our mission, but this milestone marks a turning point. It demonstrates not only our ability to deliver real-world solutions, but also our deep commitment to the long-term transformation of the healthcare system. I wish to recognize the outstanding work of our team," added Marc Lemieux , Chief Executive Officer and Chairman of the Board of KDA.
KDA extends its sincere congratulations to its development team for successfully completing this crucial phase, reinforcing the Corporation's position as a leading player in digital health innovation in Québec and beyond.
ABOUT KDA GROUP
KDA Group is a leader in technological innovations and specialized software solutions (SaaS – Software as a service) for the healthcare professionals' market. KDA is a corporation that offers quality products and has respected expertise among the various stakeholders in the pharmaceutical and medical sectors. The technology products developed by KDA aim, among other things, to accelerate the healthcare's digital transformation, and are available for the Canadian and international markets. Additional information about the Corporation is available at www.groupkda.com and on SEDAR+ at www.sedarplus.ca .
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
This press release from KDA Group contains forward-looking statements. Forward-looking statements are typically identified by the words assumption , goal , guidance , objective , outlook , strategy , target, and other similar expressions, or future or conditional verbs such as aim , anticipate , believe , predict , could , expect , intend , may , plan , seek , should , strive, and will . By their nature, forward-looking statements require us to make estimates and assumptions and express opinions based on current conditions and anticipated developments, as well as other factors that Management may deem appropriate under the circumstances. There is inherent uncertainty and significant risk in these estimates, assumptions, and opinions, particularly of a commercial, economic, and competitive nature, and they are therefore subject to change. KDA Group cannot guarantee that these estimates, assumptions, and opinions will prove to be accurate.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
SOURCE KDA Group Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/April2025/15/c0579.html
FAQ**
What specific advantages does KDA Group Inc. KDA:CC anticipate Medherize will bring to healthcare professionals once fully integrated with the Dossier Santé Québec (DSQ) by May 2025?
How does KDA Group Inc. KDA:CC plan to support the rapid rollout of the Medherize platform across various healthcare institutions in Québec post-deployment?
What challenges did KDA Group Inc. KDA:CC encounter during the initial certification phases for Medherize with DSQ, and how were they overcome?
In what ways does KDA Group Inc. KDA:CC's certification for the granular data mode differentiate its Medherize platform from competitors in the digital health space?
**MWN-AI FAQ is based on asking OpenAI questions about Kda Group Inc. (TSXVC: KDA:CC).
NASDAQ: KDA:CC
KDA:CC Trading
-4.55% G/L:
$0.105 Last:
2,500 Volume:
$0.11 Open:
